Diabetes Prevention Moves Towards Reality as Studies Published Diabetes Prevention Moves Towards Reality as Studies Published

Newly published 3-year data on teplizumab in high-risk individuals and combination therapy with liraglutide in new-onset type 1 diabetes show preserving beta-cell function may be feasible.Medscape Medical News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Diabetes & Endocrinology News Source Type: news